Home › Trial NCT00005997
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
- Trial IDNCT00005997
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorCase Comprehensive Cancer Center
- Enrollment72
- Start date1999-04
- ConditionsExtrahepatic Bile Duct Cancer · Gallbladder Cancer · Liver Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.